The role of gangliosides in neurodevelopment

Nutrients

Volumn 7, Issue 5, 2015, Pages 3891-3913

  Palmano, Kate ^a   Rowan, Angela ^b   Guillermo, Rozey ^c   Guan, Jian ^c   McJarrow, Paul ^b  

^a Fonterra Co operative Group Ltd ^*  (New Zealand)

^b FONTERRA RESEARCH CENTRE   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Brain; Cognition; Gangliosides; Neurodevelopment; Neuroplasticity; Nutrition

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1B; GLYCOLIPID; SIALIDASE; DOPAMINE;

ALZHEIMER DISEASE; CELL RENEWAL; CLINICAL TRIAL (TOPIC); COGNITION; DIETARY INTAKE; HUMAN; LEARNING DISORDER; MEMORY; MOTOR DYSFUNCTION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; RETROGRADE AMNESIA; REVIEW; SENSORY DYSFUNCTION; SPATIAL LEARNING; WEIGHT REDUCTION; ANIMAL; ARTIFICIAL MILK; BRAIN; DIET; GROWTH, DEVELOPMENT AND AGING; INFANT; METABOLISM; PHYSIOLOGY; SYNAPSE;

ANIMALS; BRAIN; COGNITION; DIET; DOPAMINE; GANGLIOSIDES; HUMANS; INFANT; INFANT FORMULA; MEMORY; NEURONAL PLASTICITY; SYNAPSES;

EID: 84930959440     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7053891     Document Type: Review

References (160)

1. Lucki, N.C.; Sewer, M.B. Nuclear sphingolipid metabolism. Ann. Rev. Physiol. 2012, 74, 131–151.
2. Ledeen, R.W.; Yu, R.K. Gangliosides-structure, isolation, and analysis. Methods Enzymol. 1982, 83, 139–191.
3. Kracun, I.; Rosner, H.; Drnovsek, V.; Vukelic, Z.; Cosovic, C.; Trbojeviccepe, M.; Kubat, M. Ganglioisides in the human brain-development and aging. Neurochem. Int. 1992, 20, 421–431.
4. Yu, R.K.; Nakatani, Y.; Yanagisawa, M. The role of glycosphingolipid metabolism in the developing brain. J. Lipid. Res. 2009, 50, S440–S445.
5. De Chaves, E.P.; Sipione, S. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 2010, 584, 1748–1759.
6. Kolter, T. Ganglioside biochemistry. ISRN Biochem. 2012, 2012, 1–36.
7. Ledeen, R. Gangliosides of the neuron. Trends Neurosci. 1985, 8, 169–174.
8. Prinetti, A.; Loberto, N.; Chigorno, V.; Sonnino, S. Glycosphingolipid behaviour in complex membranes. Biochim. Biophy. Acta-Biomembranes 2009, 1788, 184–193.
9. Schnaar, R.L.; Gerardy-Schahn, R.; Hildebrandt, H. Sialic acid in the brain: Gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol. Rev. 2014, 94, 461–518.
10. Lopez, P.H.H.; Schnaar, R.L. Gangliosides in cell recognition and membrane protein regulation. Curr. Opin. Struct. Biol. 2009, 19, 549–557.
11. Inokuchi, J.-I. Membrane microdomains and insulin resistance. FEBS Lett. 2010, 584, 1864–1871.
12. Nowycky, M.C.; Wu, G.; Ledeen, R.W. Glycobiology of ion transport in the nervous system. Adv. Neurobiol. 2014, 9, 321–342.
13. Todeschini, A.R.; Hakomori, S.-I. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta-Gen. Subj. 2008, 1780, 421–433.
14. Morgan, B.L.G. Nutritional requirements for normative development of the brain and behavior. Ann. NY. Acad. Sci. 1990, 602, 127–132.
15. Georgieff, M.K. Nutrition and the developing brain: Nutrient priorities and measurement. Amer. J. Clin. Nutr. 2007, 85, 614S–620S.
16. Uauy, R.; Mena, P.; Peirano, P. Mechanisms for nutrient effects on brain development and cognition. Nestle Nutr. Workshop Ser. Clin. Perform. Program. 2001, 5, 41–70.
17. Chiavegatto, S.; Sun, J.; Nelson, R.J.; Schnaar, R.L. A functional role for complex gangliosides: Motor deficits in GM2/GD2 synthase knockout mice. Exp. Neurol. 2000, 166, 227–234.
18. Kracun, I.; Rosner, H.; Drnovsek, V.; Heffer-Lauc, M.; Cosovic, C.; Lauc, G. Human brain gangliosides in development, aging and disease. Int. J. Devel. Biol. 1991, 35, 289–295.
19. Wu, G.S.; Lu, Z.H.; Wang, J.F.; Wang, Y.; Xie, X.; Meyenhofer, M.F.; Ledeen, R.W. Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: Protection with LIGA 20, a membrane-permeant analog of GM1. J. Neurosci. 2005, 25, 11014–11022.
20. Yu, R.K.; Tsai, Y.-T.; Ariga, T. Functional roles of gangliosides in neurodevelopment: An overview of recent advances. Neurochem. Res. 2012, 37, 1230–1244.
21. Bruel-Jungerman, E.; Davis, S.; Laroche, S. Brain plasticity mechanisms and memory: A party of four. Neuroscientist 2007, 13, 492–505.
22. Tam, S.J.; Watts, R.J. Connecting vascular and nervous system development: Angiogenesis and the blood-brain barrier. Ann. Rev. Neurosci. 2010, 33, 379–408.
23. Kolb, B.; Gibb, R. Brain plasticity and behaviour in the developing brain. J. Can. Acad. Child. Adolesc. Psychiatry 2011, 20, 265–276.
24. Thompson, R.A.; Nelson, C.A. Developmental science and the media: Early brain development. Am. Psychol. 2001, 56, 5–15.
25. Murphy, T.; Dias, G.P.; Thuret, S. Effects of diet on brain plasticity in animal and human studies: Mind the gap. Neural Plast. 2014, 2014, 563160–563160.
26. Schauer, R. Sialic acids: Fascinating sugars in higher animals and man. Zool. 2004, 107, 49–64.
27. Rosenber, A.; Stern, N. Changes in sphingosine and fatty acid components of gangliosides in developing rat and human brain. J. Lipid. Res. 1966, 7, 122–131.
28. Svennerholm, L. Chromatographic separation of human brain gangliosides. J. Neurochem. 1963, 10, 613–623.
29. Yu, R.K.; Tsai, Y.T.; Ariga, T.; Yanagisawa, M. Structures, biosynthesis, and functions of gangliosides—An overview. J. Oleo. Sci. 2011, 60, 537–544.
30. Mendez-Otero, R.; Pimentel, P.M.; Ukrainstev, S.; McJarrow, P. Role of gangliosides in neurological development. In Nutrition in infancy; Waton, R.R., Grimble, G., Preedy, V.R., Zibadi, S., Eds.; Humana Press: New York, NY, USA, 2013; Volume 2, pp. 105–118.
31. Ngamukote, S.; Yanagisawa, M.; Ariga, T.; Ando, S.; Yu, R.K. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J. Neurochem. 2007, 103, 2327–2341.
32. Yu, R.K.; Macala, L.J.; Taki, T.; Weinfeld, H.M.; Yu, F.S. Developmental-changes in ganglioside composition and synthesis in embryonic rat-brain. J. Neurochem. 1988, 50, 1825–1829.
33. Ando, S.; Chang, N.C.; Yu, R.K. High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species. Anal. Biochem. 1978, 89, 437–450.
34. Rahmann, H. Brain gangliosides and memory formation. Behav. Brain Res. 1995, 66, 105–116.
35. Svennerholm, L.; Bostrom, K.; Fredman, P.; Mansson, J.E.; Rosengren, B.; Rynmark, B.M. Human brain gangliosides-developmental changes from early fetal stage to advanced age. Biochim. Biophys. Acta 1989, 1005, 109–117.
36. Kinney, H.C. Human myelination and perinatal white matter disorders. J. Neurolog. Sci. 2005, 228, 190–192.
37. Segler-Stahl, K.; Webster, J.C.; Brunngraber, E.G. Changes in the concentration and composition of human brain gangliosides with aging. Gerontology 1983, 29, 161–168.
38. Sandhoff, K.; Kolter, T. Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans. R. Soc. Lond. B Biol. Sci. 2003, 358, 847–861.
39. Maccioni, H.J.F. Glycosylation of glycolipids in the golgi complex. J. Neurochem. 2007, 103, 81–90.
40. Proia, R.L. Gangliosides help stabilize the brain. Nat. Genet. 2004, 36, 1147–1148.
41. Wang, B. Molecular mechanism underlying sialic acid as an essential nutrient for brain development and cognition. Adv. Nutr. 2012, 3, 465S–472S.
42. Rueda, R.; Gil, A. Role of gangliosides in infant nutrition. In Lipids in infant nutrition, Huang, Y.S., Sinclair, A.J., Eds. AOAC Press: Champaign, IL, USA, 1998; pp. 213–234.
43. Sandhoff, K.; Harzer, K. Gangliosides and gangliosidoses: Principles of molecular and metabolic pathogenesis. J. Neurosci. 2013, 33, 10195–10208.
44. Derry, D.M.; Wolfe, L.S. Gangliosides in isolated neurons and glial cells. Science 1967, 158, 1450–1452.
45. Allende, M.L.; Proia, R.L. Simplifying complexity: Genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function. Glycoconj. J. 2014, 31, 613–622.
46. Wang, J.; Cheng, A.; Wakade, C.; Yu, R.K. Ganglioside GD3 is required for neurogenesis and long-term maintenance of neural stem cells in the postnatal mouse brain. J. Neurosci. 2014, 34, 13790–13800.
47. Ribeiro-Resende, V.T.; Gomes, T.A.; de Lima, S.; Nascimento-Lima, M.; Bargas-Rega, M.; Santiago, M.F.; de Melo Reis, R.A.; de Mello, F.G. Mice lacking GD3 synthase display morphological abnormalities in the sciatic nerve and neuronal disturbances during peripheral nerve regeneration. PLoS One 2014, 9, e108919.
48. Tajima, O.; Egashira, N.; Ohmi, Y.; Fukue, Y.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Inokuchi, J.; Sugiura, Y.; Furukawa, K.; et al. Reduced motor and sensory functions and emotional response in GM3-only mice: Emergence from early stage of life and exacerbation with aging. Behav. Brain Res. 2009, 198, 74–82.
49. Tajima, O.; Egashira, N.; Ohmi, Y.; Fukue, Y.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Sugiura, Y.; Furukawa, K.; Furukawa, K. Dysfunction of muscarinic acetylcholine receptors as a substantial basis for progressive neurological deterioration in GM3-only mice. Behav. Brain Res. 2010, 206, 101–108.
50. Simpson, M.A.; Cross, H.; Proukakis, C.; Priestman, D.A.; Neville, D.C.A.; Reinkensmeier, G.; Wang, H.; Wiznitzer, M.; Gurtz, K.; Verganelaki, A.; et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat. Genet. 2004, 36, 1225–1229.
51. Utz, J.R.J.; Crutcher, T.; Schneider, J.; Sorgen, P.; Whitley, C.B. Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses. Mol. Gen. Metab. 2015, 114, 274–280.
52. Bisel, B.; Pavone, F.S.; Calamai, M. GM1 and GM2 gangliosides: Recent developments. Biomol. Concepts 2014, 5, 87–93.
53. Park, E.J.; Suh, M.; Thomson, B.; Thomson, A.B.R.; Ramanujam, K.S.; Clandinin, M.T. Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. Glycobiology 2005, 15, 935–942.
54. Rueda, R.; Sabatel, J.L.; Maldonaldo, J.; Molina-Font, J.A.; Gil, A. Addition of gangliosides to an adapted milk formula modifies levels of fecal escherichia coli in preterm newborn infants. J. Pediatr. 1998, 133, 90–94.
55. Schneider, J.S.; Gollomp, S.M.; Sendek, S.; Colcher, A.; Cambi, F.; Du, W. A randomized, controlled, delayed start trial of GM1 ganglioside in treated parkinson's disease patients. J. Neurol. Sci. 2013, 324, 140–148.
56. Argentino, C.; Sacchetti, M.L.; Toni, D. GM1 ganglioside therapy in acute ischemic stroke-response. Stroke 1990, 21, 825–825.
57. Geisler, F.H.; Coleman, W.P.; Grieco, G.; Poonian, D.; Sygen Study, G. The sygen® multicenter acute spinal cord injury study. Spine 2001, 26, S87–S98.
58. Roisen, F.J.; Bartfeld, H.; Nagele, R.; Yorke, G. Ganglioside stimulation of axonal sprouting in vitro. Science 1981, 214, 577–578.
59. Byrne, M.C.; Ledeen, R.W.; Roisen, F.J.; Yorke, G.; Sclafani, J.R. Ganglioside-induced neuritogenesis: Verification that gangliosides are the active agents, and comparison of molecular species. J. Neurochem. 1983, 41, 1214–1222.
60. Tsuji, S.; Arita, M.; Nagai, Y. GQ1b, a bioactive ganglioside that exhibits novel nerve growth factor (NGF)-like activities in the two neuroblastoma cell lines. J. Biochem. 1983, 94, 303–306.
61. Gorio, A. Ganglioside enhancement of neuronal differentation, plasticity, and repair. CRC Crit. Rev. Clin. Neurobiol. 1986, 2, 241–296.
62. Ferreira, A.; Busciglio, J.; Landa, C.; Caceres, A. Ganglioside-enhanced neurite growth: Evidence for a selective induction of high-molecular-weight MAP-2. J. Neurosci. 1990, 10, 293–302.
63. Doherty, P.; Ashton, S.V.; Skaper, S.D.; Leon, A.; Walsh, F.S. Ganglioside modulation of neural cell-adhesion molecule and N-cadherin-dependent neurite outgrowth. J. Cell Biol. 1992, 117, 1093–1099.
64. Wu, G.; Fang, Y.; Lu, Z.H.; Ledeen, R.W. Induction of axon-like and dendrite-like processes in neuroblastoma cells. J. Neurocytol. 1998, 27, 1–14.
65. Ichikawa, N.; Iwabuchi, K.; Kurihara, H.; Ishii, K.; Kobayashi, T.; Sasaki, T.; Hattori, N.; Mizuno, Y.; Hozumi, K.; Yamada, Y. et al. Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. J. Cell Sci. 2009, 122, 289–299.
66. Wang, J.; Yu, R.K. Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro. Proc. Nat. Acad. Sci. 2013, 110, 19137–19142.
67. Mendez-Otero, R.; Santiago, M.F. Functional role of a specific ganglioside in neuronal migration and neurite outgrowth. Brazil. J. Med. Biol. Res. 2003, 36, 1003–1013.
68. Santiago, M.F.; Liour, S.S.; Mendez-Otero, R.; Yu, R.K. Glial-guided neuronal migration in P19 embryonal carcinoma stem cell aggregates. J. Neurosci. Res. 2005, 81, 9–20.
69. Stojiljkovic, M.; Blagojevic, T.; Vukosavic, S.; Zvezdina, N.; Pekovic, S.; Nikezic, G.; Rakic, L. Ganglioside GM1 and GM3 in early brain development: An immunocytochemical study. Int. J. Dev. Neurosci. 1996, 14, 35–44.
70. Mochetti. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol. Life Sci. 2005, 62, 2283–2294.
71. Bieberich, E.; MacKinnon, S.; Silva, J.; Yu, R.K. Regulation of apoptosis during neuronal differentiation by ceramide and b-series complex gangliosides. J. Biol. Chem. 2001, 276, 44396–44404.
72. Nakatsuji, Y.; Miller, R.H. Selective cell-cycle arrest and induction of apoptosis in proliferating neural cells by ganglioside GM3. Exp. Neurol. 2001, 168, 290–299.
73. Ohmi, Y.; Tajima, O.; Ohkawa, Y.; Furukawa, K.; Furukawa, K. Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues. J. Neurochem. 2010, 113, 21.
74. Ohmi, Y.; Ohkawa, Y.; Yamauchi, Y.; Tajima, O.; Furukawa, K.; Furukawa, K. Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues. Neurochem. Res. 2012, 37, 1185–1191.
75. Ohmi, Y.; Tajima, O.; Ohkawa, Y.; Yamauchi, Y.; Sugiura, Y.; Furukawa, K.; Furukawa, K. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: Elucidation by a series of ganglioside-deficient mutant mice. J. Neurochem. 2011, 116, 926–935.
76. Yang, L.J.S.; Zeller, C.B.; Shaper, N.L.; Kiso, M.; Hasegawa, A.; Shapiro, R.E.; Schnaar, R.L. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Nat. Acad. Sci. 1996, 93, 814–818.
77. Sheikh, K.A.; Sun, J.; Liu, Y.J.; Kawai, H.; Crawford, T.O.; Proia, R.L.; Griffin, J.W.; Schnaar, R.L. Mice lacking complex gangliosides develop wallerian degeneration and myelination defects. Proc. Nat. Acad. Sci. 1999, 96, 7532–7537.
78. Vajn, K.; Viljetic, B.; Degmecic, I.V.; Schnaar, R.L.; Heffer, M. Differential distribution of major brain gangliosides in the adult mouse central nervous system. PLoS One 2013, 8, e75720.
79. Ledeen, R.W.; Wu, G.S. Ganglioside function in calcium homeostasis and signaling. Neurochem. Res. 2002, 27, 637–647.
80. Ledeen, R.W.; Wu, G. Nuclear sphingolipids: Metabolism and signaling. J. Lipid Res. 2008, 49, 1176–1186.
81. Tanaka, Y.; Waki, H.; Kon, K.; Ando, S. Gangliosides enhance KCl-induced Ca2+ influx and acetylcholine release in brain synaptosomes. Neuroreport 1997, 8, 2203–2207.
82. Mizutani, A.; Kuroda, Y.; Muramoto, K.; Kobayashi, K.; Yamagishi, K.; Inokuchi, J. Effects of glucosylceramide synthase inhibitor and ganglioside GQ1b on synchronous oscillations of intracellular Ca2+ in cultured cortical neurons. Biochem. Biophys. Res. Comm. 1996, 222, 494–498.
83. Cooke, S.F.; Bliss, T.V.P. Plasticity in the human central nervous system. Brain 2006, 129, 1659–1673.
84. Nonaka, M.; Fujii, H.; Kim, R.; Kawashima, T.; Okuno, H.; Bito, H. Untangling the two-way signalling route from synapses to the nucleus, and from the nucleus back to the synapses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014, 369, doi:10.1098/rstb.2013.0150.
85. Kesner, R.P. Behavioral functions of the CA3 subregion of the hippocampus. Learn. Mem. 2007, 14, 771–781.
86. Egorushkina, N.V.; Ratushnyak, A.S.; Egorushkin, I.V. The influence of exogenous gangliosides on the dynamics of the development of prolonged posttetanic potentiation. Neurosci. Behav. Phys. 1993, 23, 435–438.
87. Bliss, T.V.P.; Collingridge, G.L. A synaptic model of memory-long term potentiation in the hippocampus. Nature 1993, 361, 31–39.
88. Fujii, S.; Igarashi, K.; Sasaki, H.; Furuse, H.; Ito, K.; Kaneko, K.; Kato, H.; Inokuchi, J.; Waki, H.; Ando, S. Effects of the mono- and tetrasialogangliosides GM1 and GQ1b on ATP-induced long-term potentiation in hippocampal CA1 neurons. Glycobiology 2002, 12, 339–344.
89. Ikarashi, K.; Fujiwara, H.; Yamazaki, Y.; Goto, J.-I.; Kaneko, K.; Kato, H.; Fujii, S.; Sasaki, H.; Fukumoto, S.; Furukawa, K.; et al. Impaired hippocampal long-term potentiation and failure of learning in beta 1,4-N-acetylgalactosaminyltransferase gene transgenic mice. Glycobiology 2011, 21, 1373–1381.
90. Fujiwara, H.; Ikarashi, K.; Yamazaki, Y.; Goto, J.-I.; Kaneko, K.; Sugita, M.; Kato, H.; Sasaki, H.; Inokuchi, J.-I.; Furukawa, K.; et al. Impairment of hippocampal long-term potentiation and failure of learning in mice treated with D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol. Biomed. Res. 2012, 33, 265–271.
91. She, J.Q.; Wang, M.; Zhu, D.M.; Sun, L.G.; Ruan, D.Y. Effect of ganglioside on synaptic plasticity of hippocampus in lead-exposed rats in vivo. Brain Res. 2005, 1060, 162–169.
92. Dunn, A.J.; Hogan, E.L. Brain gangliosides: Increased incorporation of (1–3 h) glucosamine during training. Pharmacol. Biochem. Behav. 1975, 3, 605–612.
93. Irwin, L.N.; Samson, F.E. Content and turnover of gangliosides in rat brain following behavioural stimulation. J. Neurochem. 1971, 18, 203–211.
94. Savaki, H.E.; Levis, G.M. Changes in rat brain gangliosides following active avoidance conditioning. Pharmacol. Biochem. Behav. 1977, 7, 7–12.
95. McJarrow, P.; Schnell, N.; Jumpsen, J.; Clandinin, T. Influence of dietary gangliosides on neonatal brain development. Nutr. Rev. 2009, 67, 451–463.
96. Wainwright, P.E.; Lomanowska, A.M.; McCutcheon, D.; Park, E.J.; Clandinin, M.T.; Ramanujam, K.S. Postnatal dietary supplementation with either gangliosides or choline: Effects on spatial short-term memory in artificially-reared rats. Nutr. Neurosci. 2007, 10, 67–77.
97. Jung, W.R.; Kim, H.G.; Kim, K.L. Ganglioside GQ1b improves spatial learning and memory of rats as measured by the y-maze and the morris water maze tests. Neurosci. Lett. 2008, 439, 220–225.
98. Mei, Z.T.; Zheng, J.Z. Effects of exogenous gangliosides on learning and memory in rats. Jpn. J. Physiol. 1993, 43, S295–S299.
99. Yang, R.; Wang, Q.; Min, L.; Sui, R.; Li, J.; Liu, X. Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of alzheimer’s disease. Neurolog. Sci. 2013, 34, 1447–1451.
100. Karpiak, S.; Graf, L.; Rapport, M. Passive avoidance learning is inhibited by antiserum to brain ganglioside. Neurosci. Abstr. 1976, 2, 443.
101. Karpiak, S.E.; Rapport, M.M. Inhibition of consolidation and retrieval stages of passive-avoidance learning by antibodies to gangliosides. Behav. Neural. Biol. 1979, 27, 146–156.
102. Crichton, G.E.; Elias, M.F.; Dore, G.A.; Robbins, M.A. Relation between dairy food intake and cognitive function: The maine-syracuse longitudinal study. Int. Dairy J. 2012, 22, 15–23.
103. Crichton, G.E.; Murphy, K.J.; Howe, P.R.C.; Buckley, J.D.; Bryan, J. Dairy consumption and working memory performance in overweight and obese adults. Appetite 2012, 59, 34–40.
104. Landon, J.; Davison, M.; Krageloh, C.U.; Thompson, N.M.; Miles, J.L.; Vickers, N.H.; Fraser, M.; Breier, B.H. Global undernutrition during gestation influences learning during adult fife. Learn. Behav. 2007, 35, 79–86.
105. Morgan, B.L.; Winick, M. Effects of administration of N-acetylneuraminic acid (NANA) on brain nana content and behavior. J. Nutr. 1980, 110, 416–424.
106. Morgan, B.L.; Winick, M. The subcellular localization of administered N-acetylneuraminic acid in the brains of well-fed and protein restricted rats. Brit. J. Nutr. 1981, 46, 231–238.
107. Morgan, B.L.; Winick, M. Effects of environmental stimulation on brain N-acetylneuraminic acid content and behavior. J. Nutr. 1980, 110, 425–432.
108. Morgan, B.L.; Naismith, D.J. The effect of early postnatal undernutrition on the growth and development of the rat brain. Brit. J. Nutr. 1982, 48, 15–23.
109. Morgan, B.L.; Oppenheimer, J.; Winick, M. Effects of essential fatty acid deficiency during late gestation on brain N-acetylneuraminic acid metabolism and behaviour in the progeny. Brit. J. Nutr. 1981, 46, 223–230.
110. Vaswani, K.K.; Sharma, M. Effect of neonatal undernutrition on rat brain gangliosides. Int. J. Vit. Nutr. Res. 1985, 55, 323–329.
111. Wang, B.; McVeagh, P.; Petocz, P.; Brand-Miller, J. Brain ganglioside and glycoprotein sialic acid in breastfed compared with formula-fed infants. Am. J. Clin. Nutr. 2003, 78, 1024–1029.
112. Lacomba, R.; Salcedo, J.; Alegria, A.; Barbera, R.; Hueso, P.; Matencio, E.; Jesus Lagarda, M. Sialic acid (N-acetyl and N-glycolylneuraminic acid) and ganglioside in whey protein concentrates and infant formulae. Int. Dairy J. 2011, 21, 887–895.
113. Rueda, R. Gangliosides, immunity, infection and inflammation. In Diet, Immunity and Inflammation; Calder, P.C., Yaqoob, P., Eds.; Woodhead Publishing Ltd.: Cambridge, UK, 2013; pp. 341–354.
114. Zhang, J.; Ren, Y.; Huang, B.; Tao, B.; Pedersen, M.R.; Li, D. Determination of disialoganglioside GD3 and monosialoganglioside GM3 in infant formulas and whey protein concentrates by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry. J. Sep. Sci. 2012, 35, 937–946.
115. Martin-Sosa, S.; Martin, M.J.; Castro, M.D.; Cabezas, J.A.; Hueso, P. Lactational changes in the fatty acid composition of human milk gangliosides. Lipids 2004, 39, 111–116.
116. Pan, X.L.; Izumi, T. Variation of the ganglioside compositions of human milk, cow’s milk and infant formulas. Early Human Dev. 2000, 57, 25–31.
117. Laegreid, A.; Otnaess, A.B.K.; Fuglesang, J. Human and bovine-milk: Comparison of ganglioside composition and enterotoxin-inhibitory activity. Pediatr. Res. 1986, 20, 416–421.
118. Takamizawa, K.; Iwamori, M.; Mutai, M.; Nagai, Y. Selective changes in gangliosides of human milk during lactation: A molecular indicator for the period of lactation. Biochim. Biophys. Acta 1986, 879, 73–77.
119. Uchiyama, S.-I.; Sekiguchi, K.; Akaishi, M.; Anan, A.; Maeda, T.; Izumi, T. Characterization and chronological changes of preterm human milk gangliosides. Nutrition 2011, 27, 998–1001.
120. Giuffrida, F.; Elmelegy, I.M.; Thakkar, S.K.; Marmet, C.; Destaillats, F. Longitudinal evolution of the conentration of gangliosides GM3 and GD3 in human milk. Lipids 2014, 49, 997–1004.
121. Rueda, R.; Puente, R.; Hueso, P.; Maldonado, J.; Gil, A. New data on content and distribution of gangliosides in human milk. Bioli. Chemi. 1995, 376, 723–727.
122. Park, E.J.; Suh, M.; Clandinin, M.T. Dietary ganglioside and long-chain polyunsaturated fatty acids increase ganglioside GD3 content and alter the phospholipid profile in neonatal rat retina. Invest. Ophthalmol. Vis. Sci. 2005, 46, 2571–2575.
123. Rueda, R.; Garcia Salmeron, J.L.; Maldonado, J.; Gil, A. Changes during lactation in ganglioside distribution in human milk from mothers delivering preterm and term infants. Bioli. Chemi. 1996, 377, 599–601.
124. Puente, R.; Garciapardo, L.A.; Hueso, P. Gangliosides in bovine-milk-changes in content and distribution of individual ganglioside levels during lactation. Bioli. Chemi. 1992, 373, 283–288.
125. Anderson, J.W.; Johnstone, B.M.; Remley, D.T. Breast-feeding and cognitive development: A meta-analysis. Am. J. Clin. Nutr. 1999, 70, 525–535.
126. Horwood, L.J.; Darlow, B.A.; Mogridge, N. Breast milk feeding and cognitive ability at 7–8 years. Arch. Dis. Child. Fetal Neonatal Ed. 2001, 84, F23–F27.
127. Syahrir, L.; Fadlyana, E.; Effendi, S.H. Comparison of language and visual-motor developments between exclusively and non-exclusively breastfed infants through cognitive adaptive test/clinical linguistic and auditory milestone scale. Paediatr. Indones. 2009, 49, 337–341.
128. Lucas, A.; Morley, R.; Cole, T.J. Randomised trial of early diet in preterm babies and later intelligence quotient. Brit. Med. J. 1998, 317, 1481–1487.
129. Isaacs, E.B.; Fischl, B.R.; Quinn, B.T.; Chong, W.K.; Gadian, D.G.; Lucas, A. Impact of breast milk on intelligence quotient, brain size, and white matter development. Pediatr. Res. 2010, 67, 357–362.
130. Willatts, P. Long chain polyunsaturated fatty acids improve cognitive development. J. Fam. Health Care 2002, 12, 5.
131. Helland, I.B.; Smith, L.; Saarem, K.; Saugstad, O.D.; Drevon, C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 2003, 111, e39–e44.
132. Lauritzen, L.; Jorgensen, M.H.; Olsen, S.F.; Straarup, E.M.; Michaelsen, K.F. Maternal fish oil supplementation in lactation: Effect on developmental outcome in breast-fed infants. Reprod. Nutr. Devel. 2005, 45, 535–547.
133. Park, E.J.; Suh, M.; Ramanujam, K.; Steiner, K.; Begg, D.; Clandinin, T.T. Diet-induced changes in membrane gangliosides in rat intestinal mucosa, plasma and brain. J. Pediatr. Gastroenterol. Nutr. 2005, 40, 487–495.
134. Hungund, B.L.; Morishima, H.O.; Gokhale, V.S.; Cooper, T.B. Placental-transfer of (H-3)-GM1 and its distribution to maternal and fetal tissues of the rat. Life Sci. 1993, 53, 113–119.
135. Watson, M.B.; Clandinin, T. Dietary ganglioside and neurochemistry in the developing rat. Glycobiology 2006, 16, 1148–1149.
136. Mitchell, M.D.; Henare, K.; Balakrishnan, B.; Lowe, E.; Fong, B.Y.; McJarrow, P. Transfer of gangliosides across the human placenta. Placenta 2012, 33, 312–316.
137. Vickers, M.H.; Guan, J.; Gustavsson, M.; Krageloh, C.U.; Breier, B.H.; Davison, M.; Fong, B.; Norris, C.; McJarrow, P.; Hodgkinson, S.C. Supplementation with a mixture of complex lipids derived from milk to growing rats results in improvements in parameters related to growth and cognition. Nutr. Res. 2009, 29, 426–435.
138. Gustavsson, M.; Hodgkinson, S.C.; Fong, B.; Norris, C.; Guan, J.A.; Krageloh, C.U.; Breier, B.H.; Davison, M.; McJarrow, P.; Vickers, M.H. Maternal supplementation with a complex milk lipid mixture during pregnancy and lactation alters neonatal brain lipid composition but lacks effect on cognitive function in rats. Nutr. Res. 2010, 30, 279–289.
139. Salvati, S.; Attorri, L.; Avellino, C.; Di Biase, A.; Sanchez, M. Diet, lipids and brain development. Devel. Neurosci. 2000, 22, 481–487.
140. Dobbing, J.; Sands, J. Comparative aspects of the brain growth spurt. Early Human Devel. 1979, 3, 79–83.
141. Liu, H.; Radlowski, E.C.; Conrad, M.S.; Li, Y.; Dilger, R.N.; Johnson, R.W. Early supplementation of phospholipids and gangliosides affects brain and cognitive development in neonatal piglets. J. Nutr. 2014, 144, 1903–1909.
142. Xu, X.Z.; Zhu, T.-C. Effect of ganglioside in repairing the neurological function of chinese children with cerebral palsy: Analysis of the curative efficacy in 2230 cases. Chin. J. Clin. Rehab. 2005, 9, 122–123.
143. Gurnida, D.A.; Rowan, A.M.; Idjradinata, P.; Muchtadi, D.; Sekarwana, N. Association of complex lipids containing gangliosides with cognitive development of 6-month-old infants. Early Human Devel. 2012, 88, 595–601.
144. Bouhours, D.; Bouhours, J.F. Developmental changes of hematoside of rat small intestine. Postnatal hydroxylation of fatty acids and sialic acid. J. Biol. Chem. 1983, 258, 299–304.
145. Holgersson, J.; Stromberg, N.; Breimer, M.E. Glycolipids of human large-intestine: Difference in glycolipid expression related to anatomical localization, epithelial non-epithelial tissue and the ABO, LE and SE phenotypes of the donors. Biochimie 1988, 70, 1565–1574.
146. Wu, C.; Bai, L.; Wang, W. Neurobehavior effect of GM-1 on LBW infants. Hei Long Jiang Med. J. 2010, 34, 410–412.
147. Hungund, B.L.; Ross, D.C.; Gokhale, V.S. Ganglioside GM1 reduces fetal alcohol effects in rat pups exposed to ethanol in utero. Alcohol. Clin. Exp. Res. 1994, 18, 1248–1251.
148. Laev, H.; Karpiak, S.E.; Gokhale, V.S.; Hungund, B.L. In-utero ethanol exposure retards growth and alters morphology of cortical cultures: GM1 reverses effects. Alcohol. Clin. Exp. Res. 1995, 19, 1226–1233.
149. Saito, M.; Mao, R.F.; Wang, R.; Vadasz, C.; Saito, M. Effects of gangliosides on ethanol-induced neurodegeneration in the developing mouse brain. Alcohol. Clin. Exp. Res. 2007, 31, 665–674.
150. Svennerholm, L.; Brane, G.; Karlsson, I.; Lekman, A.; Ramstrom, I.; Wikkelso, C. Alzheimer disease: Effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. Dement. Geriatr. Cogn. Disord. 2002, 14, 128–136.
151. Guillermo, R.B.; Yang, P.; Vickers, M.H.; McJarrow, P.; Guan, J. Supplementation with complex milk lipids during brain development promotes neuroplasticity without altering myelination or vascular density. Food Nutr. Res. 2015, 59, 25765.
152. Agnati, L.F.; Fuxe, K.; Calza, L.; Benfenati, F.; Cavicchioli, L.; Toffano, G.; Goldstein, M. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Acta Physiol. Scand. 1983, 119, 347–363.
153. Fong, T.G.; Neff, N.H.; Hadjiconstantinou, M. GM1 ganglioside improves spatial learning and memory of aged rats. Behav. Brain Res. 1997, 85, 203–211.
154. Silva, R.H.; Felicio, L.F.; Nasello, A.G.; Vital, M.; Frussa, R. Effect of ganglioside (GM1) on memory in senescent rats. Neurobiol. Aging 1996, 17, 583–586.
155. Guan, J.; MacGibbon, A.; Zhang, R.; Elliffe, D.M.; Moon, S.; Liu, D.-X. Supplementation of complex milk lipid concentrate (CMLc) improved the memory of aged rats. Nutr. Neurosci. 2015, 18, 22–29.
156. Mattson, M.P. Glutamate and neurotrophic factors in neuronal plasticity and disease. In Neural signaling: Opportunities for novel diagnostic approaches and therapies; Goetzl, E.J., Ed.; Wiley-Blackwell: Boston, MA, USA, 2008; Volume 1144, pp. 97–112.
157. Backman, L.; Lindenberger, U.; Li, S.-C.; Nyberg, L. Linking cognitive aging to alterations in dopamine neurotransmitter functioning: Recent data and future avenues. Neurosci. Biobehav. Rev. 2010, 34, 670–677.
158. Nitsche, M.A.; Kuo, M.-F.; Grosch, J.; Bergner, C.; Monte-Silva, K.; Paulus, W. D-1-receptor impact on neuroplasticity in humans. J. Neurosci. 2009, 29, 2648–2653.
159. Ryan, J.M.; Rice, G.E.; Mitchell, M.D. The role of gangliosides in brain development and the potential benefits of perinatal supplementation. Nutr. Res. 2013, 33, 877–887.
160. Poppitt, S.D.; McGregor, R.A.; Wiessing, K.R.; Goyal, V.K.; Chitkara, A.J.; Gupta, S.; Palmano, K.; Kuhn-Sherlock, B.; McConnell, M.A. Bovine complex milk lipid containing gangliosides for prevention of rotavirus infection and diarrhoea in northern indian infants. J. Pediatr. Gastroenterol. Nutr. 2014, 59, 167–171.